What is the recommended dose of STEMetil (Prochlorperazine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Dosage of Prochlorperazine (STEMetil)

The recommended dose of prochlorperazine (STEMetil) is 5-10 mg orally every 6-8 hours or 5-10 mg IV every 6-8 hours, with a maximum daily dose of 40 mg. 1

Dosage Forms and Routes of Administration

Oral Administration

  • Standard dose: 10 mg every 6 hours as needed 2, 1
  • Daily maximum: 40 mg 2

Intravenous Administration

  • Standard dose: 5-10 mg IV every 6-8 hours 1
  • For rapid control: 2.5-5 mg IV provides faster relief than oral administration 1, 3
  • IV administration achieves approximately 100% bioavailability with plasma concentrations more than twice as high as oral administration 1

Rectal Administration

  • Standard dose: 25 mg suppository every 12 hours 2

Indications and Clinical Applications

Antiemetic Therapy

  • Effective for nausea and vomiting in various settings:
    • Low emetogenic risk chemotherapy 2
    • Breakthrough treatment for chemotherapy-induced nausea/vomiting 2
    • Acute dizziness with associated nausea and vomiting 4
    • Cyclic vomiting syndrome (CVS) 2

Specific Clinical Scenarios

  • Acute migraine: Effective in pediatric emergency department settings when combined with diphenhydramine to prevent akathisia 5
  • Acute myocardial infarction: 2.5 mg IV has been shown to effectively relieve nausea and vomiting without causing symptomatic hypotension 3

Monitoring and Adverse Effects

Common Adverse Effects

  • CNS depression
  • Anticholinergic effects
  • Extrapyramidal symptoms
  • Drug-induced leukopenia or neutropenia (rare)
  • Neuroleptic malignant syndrome (rare) 2

Special Precautions

  • Monitor for dystonic reactions: Use diphenhydramine 25-50 mg PO or IV every 4-6 hours for dystonic reactions 2
  • If allergic to diphenhydramine, use benztropine 1-2 mg IV or IM for one dose, followed by oral dose of 1-2 mg daily or BID if needed 2
  • Peripheral IV administration: Can cause tissue injury, including gangrene or thrombophlebitis 2
  • Use with caution in patients with:
    • History of leukopenia or neutropenia
    • Dementia
    • Glaucoma
    • Seizure disorder 2

Drug Interactions

  • Prochlorperazine can interact with dofetilide and should be avoided in combination 2
  • May cause QT prolongation when used with other QT-prolonging medications 2

Efficacy Data

  • In a real-world study, prochlorperazine at a mean dose of 14.9 mg/day for a mean duration of 7.2 days was well-tolerated and effective for acute dizziness 4
  • Only 0.006% of patients reported adverse drug reactions (headache, asthenia, somnolence) which were mild and resolved completely 4

Clinical Pearl

When administering prochlorperazine IV for rapid control of severe nausea and vomiting, consider starting with a lower dose of 2.5 mg in hemodynamically vulnerable patients (such as those with acute myocardial infarction), as this has been shown to be effective while minimizing the risk of hypotension 3.

References

Guideline

Antiemetic Therapy with Prochlorperazine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The Real-World Safety and Effectiveness of Prochlorperazine in Indian Patients with Dizziness.

The Journal of the Association of Physicians of India, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.